Home » Topics » BioWorld Science

BioWorld Science
RSS

Serotonergic agents prepared at Merck KGaA as potential antidepressants/anxiolytics

Jan. 14, 1998

Vertex describes new IMPDH inhibitors

Jan. 14, 1998

Novartis discloses HIV protease inhibitors with excellent pharmacodynamic profile

Jan. 14, 1998

PDE IV/TNF production inhibitors claimed by Schering AG for MS

Jan. 14, 1998

U.S. marketing application submitted for AD-32

Jan. 14, 1998

New use approved for Lescol

Jan. 14, 1998

Photofrin enters phase III testing for new indication

Jan. 14, 1998

Eisai in-licenses antiobesity drug for Japanese market

Jan. 14, 1998

Nastech licenses nasal scopolamine to Schwarz

Jan. 14, 1998

Atrix receives CE mark approval for Atrisorb; ISO 9001 certification granted

Jan. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...